| Autor: |
Soni, Abhishek, Paul, Diptajit, Verma, Monica, Kaur, Paramjeet, Chauhan, Ashok, Kaushal, Vivek |
| Předmět: |
|
| Zdroj: |
Oncology in Clinical Practice (2450-1654); 2023, Vol. 19 Issue 3, p158-166, 9p |
| Abstrakt: |
Incidence of male breast carcinoma (MBC), although rare, recently has an increasing trend. The increase in incidence is associated with increasing age, and poor clinical outcome seen with MBC is mostly because of illiteracy and lack of health education and shyness in reporting to the clinical physician. In this context, a comprehensive review regarding this forth bursting clinical scenario is important. The present article focus on that aspect encompassing but not limited to different clinical studies. The randomized trials on MBC are sparse and most of the studies are retrospective in nature due to rarity of cases. MBC treatment line is derived from female breast cancer guidelines. MBC has a poorer prognosis than female breast cancer. MBC patients in India present in advanced stage and surgery remains challenging due to paucity of breast tissue. Post mastectomy radiation is indicated on the same lines as of female breast cancer and it decreases locoregional recurrence. Adjuvant hormonal therapy decreases recurrence and improves survival. Further clinical trials are required including large number of patients to study different parameters in respect of prognosis and survival. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
